Pulmonary Infections: Pathogenesis and Antimicrobial Treatment
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (15 November 2024) | Viewed by 9777
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pulmonary infections remain a leading cause of morbidity and mortality worldwide, yet their underlying mechanisms are not completely understood. The severity of clinical presentation depends on a complex host–microbe interaction, immune resistance, tissue resilience, and changes in microbiome. In the last two years, we have witnessed a dramatic worldwide increase in hospitalizations for pneumonia caused by SARS-CoV-2 infection with high mortality rates. SARS-CoV-2 as well as other viral infections may also predispose patients to potentially fatal secondary bacterial or fungal infections. Furthermore, the increasing antimicrobial resistance is a major challenge as respiratory infections caused by multidrug-resistant bacteria are associated with a greater likelihood of inappropriate antimicrobial therapy and poor clinical outcomes. This Special Issue welcomes submissions of original and review articles that investigate the etiologies, pathogenesis, immunology, treatments, and outcomes of respiratory infections.
Dr. Marija Vukoja
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- respiratory infections
- pathogenesis
- antibiotics
- treatment
- outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.